Otros idiomas Aurinia Pharmaceuticals Inc.

Acciones

AUPH

CA05156V1022

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 01/05/2024			Varia. Cinco días.	Varia. 1 de enero.
5,2 ^USD	+2,16 %		+3,38 %	-42,16 %

30/04	Aurinia Pharmaceuticals Inc. anuncia que la FDA aprueba la actualización de la etiqueta de LUPKYNIS® para incluir los datos a largo plazo del programa clínico AURORA	CI
20/03	ILJIN SNT entrega una carta a Aurinia Pharmaceuticals	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

AURINIA PHARMACEUTICALS - THE U.S. FOOD & DRUG ADMINISTRATION APPROVES UPDATED LUPKYNIS LABEL TO INCLUDE LONG-TERM DATA FROM THE AURORA CLINICAL PROGRAM	01/05
Aurinia Underscores Enduring Commitment to People Living with Lupus Nephritis Through Innovative Advocacy and Education Initiatives for Lupus Awareness Month	01/05
The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program	30/04
Aurinia Pharmaceuticals Inc. Announces The U.S. Food & Drug Administration Approves Updated LUPKYNIS® Label to include Long-Term Data from the AURORA Clinical Program	30/04
UPDATE, NEW AURINIA PRESENTATION DETAILS AT THE 2024 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE	17/04
New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference	16/04
Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024	15/04
Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference	09/04
ILJIN SNT Delivers a Letter to Aurinia Pharmaceuticals	20/03
Aurinia Pharmaceuticals Insider Sold Shares Worth $711,094, According to a Recent SEC Filing	07/03
Aurinia Pharmaceuticals Insider Sold Shares Worth $323,372, According to a Recent SEC Filing	07/03
Aurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase Program	29/02
Aurinia to Participate in Upcoming Investor Healthcare Conferences	27/02
Sector Update: Health Care Stocks Higher Late Afternoon	15/02
Sector Update: Health Care Stocks Higher Thursday Afternoon	15/02
Sector Update: Health Care	15/02
Aurinia Pharmaceuticals Q4 Loss Widens, Revenue Increases; Concludes Strategic Review -- Shares Slump	15/02
Aurinia: Q4 Earnings Snapshot	15/02
Aurinia Pharmaceuticals Inc. announces an Equity Buyback for $150 million worth of its shares.	15/02
Earnings Flash (AUPH) AURINIA PHARMACEUTICALS Posts Q4 Revenue $45.1M, vs. Street Est of $45.2M	15/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Aurinia Pharmaceuticals Inc.

Acciones

AUPH

CA05156V1022

Otros idiomas

Filtros